News tagged with intellectual property
Lab boost for precious anti-malaria drug
US scientists on Wednesday said they had used baker's yeast to make a key ingredient of malaria drugs, a feat that could iron out fluctuations in supply caused by sourcing the chemical from a Chinese herb.
Diseases, Conditions, Syndromes
Apr 10, 2013 |
5 / 5 (1) |
0
Big Pharma battle threatens to delay Pacific trade pact
A US-led Pacific free trade pact faces further delays as a row between Big Pharma and activists supporting access to generic drugs erupts ahead of an October deadline, officials say.
Medications
Mar 10, 2013 |
not rated yet |
1
India rejects Bayer plea against cheap cancer drug (Update)
India's patent appeals office has rejected Bayer AG's plea to stop the production of a cheaper generic version of a patented cancer drug in a ruling that health groups say is an important precedent for getting ...
Medications
Mar 05, 2013 |
5 / 5 (4) |
3
Bayer vows to fight for patent on anti-cancer drug in India
German pharmaceuticals giant Bayer, maker of Aspirin, vowed Monday to fight a ruling by the patent authorities in India allowing a local company to produce and sell a generic copy of its anti-cancer drug Nexavar.
Medications
Mar 04, 2013 |
not rated yet |
0
Australia introduces plain packaging for cigarettes
A law forcing tobacco firms to sell cigarettes in plain packets came into effect in Australia on Saturday in an effort to strip any glamour from smoking and prevent young people from taking up the habit.
Health
Dec 01, 2012 |
not rated yet |
4
International action needed to ensure the quality of medicines and tackle the fake drugs trade
Their call comes just days before 100 World Health Organisation member states hold their first meeting to discuss the problem, and the authors hope it will help to influence the debate and lead to some concrete actions.
Medications
Nov 13, 2012 |
not rated yet |
0
Peer review option proposed for biodiversity data
Data publishers should have the option of submitting their biodiversity datasets for peer review, according to a discussion paper commissioned by the Global Biodiversity Information Facility (GBIF).
Other
Oct 25, 2012 |
not rated yet |
0
Bayer 'disappointed' after losing India patent fight
Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.
Medications
Sep 26, 2012 |
not rated yet |
0
WHO hails Australia tobacco packaging ban
The World Health Organization on Wednesday welcomed the decision by Australia's High Court to dismiss a legal challenge against plain cigarette packaging and hoped it would have a "domino effect" in other countries. ...
Health
Aug 15, 2012 |
5 / 5 (2) |
0
Australian court defers ruling on tobacco packaging
Australian judges hearing a legal challenge to new laws requiring plain packaging for cigarettes deferred their decision Thursday until a later date, yet to be decided.
Health
Apr 19, 2012 |
not rated yet |
0
Australia takes on big tobacco firms in court
Australia said it was confident of seeing off a court challenge Tuesday by big tobacco firms over plain-packaging for cigarettes, in a test case being watched by governments around the world.
Health
Apr 17, 2012 |
5 / 5 (1) |
0
US Supreme Court rejects blood monitoring patents
Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine.
Other
Mar 21, 2012 |
5 / 5 (1) |
1
Bayer mulls challenge to India cancer drug ruling
Bayer AG said Tuesday it was mulling ways to challenge a ground-breaking Indian ruling allowing a local firm to produce a vastly cheaper copy of a cancer drug made by the German pharmaceutical giant.
Medications
Mar 13, 2012 |
not rated yet |
0
India licenses generic copy of patented Bayer drug
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Medications
Mar 12, 2012 |
5 / 5 (4) |
0
India's global pharmacy role threatened by EU pact
(AP) -- Efforts by India and the European Union to strengthen trade are threatening India's ability to deliver lifesaving medicines to the world's poorest, analysts say as the two sides push through protracted ...
Medications
Feb 10, 2012 |
not rated yet |
0
Intellectual property
Intellectual property (IP) is a number of disparate types of legal monopolies over creations of the mind, both artistic and commercial, and the corresponding fields of law. Under intellectual property law, owners are granted certain exclusive rights to a variety of intangible assets, such as musical, literary, and artistic works; ideas, discoveries and inventions; and words, phrases, symbols, and designs. Common types of intellectual property include copyrights, trademarks, patents, industrial design rights and trade secrets in some jurisdictions.
The majority[which?] of intellectual property rights provide creators of original works a form of temporary monopoly with the aim of creating an economic incentive to develop and share ideas.
Although many of the legal principles governing intellectual property have evolved over centuries, it was not until the 19th century that the term intellectual property began to be used, and, it is said, not until the late 20th century that it became commonplace in the United States.
For more information about Intellectual property, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
